KUALA LUMPUR, Feb 23 (Bernama) -- Public-listed healthcare company, Malaysian Genomics Resource Centre Berhad (MGRC), and its subsidiary, pathology services company Clinipath (Malaysia) Sdn Bhd (Clinipath) today announced the availability of Dtect BRCA+, an affordable genetic screening test that examines key genes associated with hereditary breast and ovarian cancers.
Breast and ovarian cancers are two of the most common cancers affecting adult women. Symptoms for breast cancer may include swelling of all or part of a breast, skin irritation, thickening of the nipple or breast skin and abnormal nipple discharge. Symptoms for ovarian cancer may include abdominal bloating, indigestion, increased urge to urinate, constipation and menstrual irregularities.
In 2018, the Ministry of Health Malaysia published the MySCan study on cancer incidence and survival rates. From the study, the incidence was observed at any age above 40 years. The mortality rate is 43.3% for breast cancer and 52.9% for ovarian cancer. Most importantly, the study found that early detection and treatment of breast cancer and ovarian cancer (at Stage 1) led to a 5-year relative survival rate of 87.5% and 82.8% respectively.
Genetic screening can identify genetic predispositions to hereditary breast and ovarian cancers. Positive results from Dtect BRCA+ may identify a need for regular, pathology surveillance to catch either of these diseases early when they are easiest to treat. Positive results may also be useful to encourage positive lifestyle changes to mitigate the risk of hereditary breast cancer or ovarian cancer from occurring.
MGRC and Clinipath continue to work together to make comprehensive pathology services, and the latest in genetic testing available to doctors with a view to improving the lives of patients in Malaysia and the region.
About Malaysian Genomics Resource Centre Berhad
MGRC was a pioneer in genome sequencing, bioinformatics analysis and genetic screening services. Since 2004, MGRC had developed extensive pipelines in the sequencing and analysis of human, animal, plant and microbial genomes for clients worldwide. Today, MGRC is focused on merging the latest in genetic testing with pathology to enable doctors to provide personalised healthcare for their patients.
About Clinipath (Malaysia) Sdn Bhd
Clinipath is one of Malaysia’s largest independent pathology service providers with a nationwide network of 18 branches. It offers a complete range of fast, accurate and reliable pathology testing services. It has been ISO 15189 accredited since 2010. Clinipath is a wholly-owned subsidiary of public-listed MGRC.
Source: Malaysian Genomics Resource Centre Berhad
FOR MORE INFORMATION, PLEASE CONTACT:
Name: Shawn Keng
Tel: +6014-9685808
Email: enquiries@mgrc.com.my
--BERNAMA
Saturday, 23 February 2019
Friday, 22 February 2019
2019 sees most world population migrating to ´cyberspace´
KUALA LUMPUR, Feb 19 (Bernama) – This year, for the first time ever, more than half of the world’s population will have internet access, says global market research company, Euromonitor International.
Yet, they are emphasising a balance in time spent online and offline, becoming more intentional and selective of digital activities.
This follows the company’s newly-revealed 2019 top five digital trends – digital wellness, autonomous outlets, voice, customer-led experiences and expansion of super apps.
“Increased connectivity, combined with technological advances, has created massive upheavals in consumer expectations, lowered the barriers of entry for fast-moving companies and inspired new digital-first commerce avenues,” noted Euromonitor International head of digital consumer, Michelle Evans.
Autonomous outlets will gain traction as companies invest in this technology to get into new channels and develop innovative business models.
Since voice-enabled devices are becoming mainstream, companies should prepare for new use cases to emerge and integrate these functions into existing strategies.
As stated by the company’s Digital Consumer Industry Insights Survey, business leaders are very concerned to improve customer journey in the coming year. Technology will also help companies deliver truly curated, personalised interactions – putting consumers in control of their shopping experiences.
Super apps which refer to mobile apps that combine several features into a single platform are going global with consumers and companies embracing their multifunctionality.
With over 40 years of experience, Euromonitor International is the world’s leading provider for global business intelligence and strategic market analysis. More details at https://www.euromonitor.com/
-- BERNAMA
BTS Recognized A Top Player In Assessments
SAN FRANCISCO, Feb 20 (Bernama-BUSINESS WIRE) — BTS, a leading global strategy implementation firm, was recently named a Top 20 Assessment and Evaluation Company by Training Industry. This marks the 32nd award BTS received in 2018.
With decades of experience in the assessment and industrial/organizational psychology space, BTS has developed a strong research-backed point of view. BTS’ wide range of cutting-edge assessments combine traditional techniques like psychological tests and behavioral observation with customized leadership and business simulation exercises. 2018 innovations to BTS assessments include the incorporation of customized simulations to provide more realistic, “day-in-the-life” experiences, and fully digital capabilities, allowing assessments to be administered from both on-site and virtual/remote locations in an immersive, engaging, highly scalable environment. BTS has also developed a new approach to situational judgement tests, evaluating an employee’s behavioral judgements during the critical moments throughout the day.
Thursday, 21 February 2019
Featurespace technology to outsmart Singapore's fraudsters
KUALA LUMPUR, Feb 21 (Bernama) -- Singapore is home to one of the world’s highest card fraud. Hence, the island republic’s financial industry in 2017 committed to data analytics to combat financial crime.
In line with this commitment, fraud detection and risk management solutions provider, Featurespace launched a groundbreaking, anti-fraud technology into the Singapore market.
The technological platform uses machine learning to detect anomalies in individual behaviour for fraud and risk management. It was first developed by the world’s leading computer scientists in Cambridge University, England.
Featurespace’s real-time ARIC™ platform uses Adaptive Behavioural Analytics to self-learn and continuously respond to new customer data.
By understanding the behaviour of each individual banking and credit card customer, ARIC identifies new and known attacks and nips fraud in the bud, while accepting more genuine businesses.
As such, ARIC reduces false positives by 70 per cent, increasing revenue and reducing customer friction.
Featurespace chief executive officer, Martina King said millions of Singaporeans fell victim to a myriad of large-scale fraud attacks in the recent past.
“By implementing machine learning technology, we can help banks and credit card providers outsmart the criminals and build safer banking infrastructure.”
According to the Anti-Money Laundering and Countering the Financing of Terrorism Industry Partnership, lenders are looking at using data analytics to detect suspicious transactions because current systems mistakenly identify fraud, resulting in declined transactions.
-- BERNAMA
In line with this commitment, fraud detection and risk management solutions provider, Featurespace launched a groundbreaking, anti-fraud technology into the Singapore market.
The technological platform uses machine learning to detect anomalies in individual behaviour for fraud and risk management. It was first developed by the world’s leading computer scientists in Cambridge University, England.
Featurespace’s real-time ARIC™ platform uses Adaptive Behavioural Analytics to self-learn and continuously respond to new customer data.
By understanding the behaviour of each individual banking and credit card customer, ARIC identifies new and known attacks and nips fraud in the bud, while accepting more genuine businesses.
As such, ARIC reduces false positives by 70 per cent, increasing revenue and reducing customer friction.
Featurespace chief executive officer, Martina King said millions of Singaporeans fell victim to a myriad of large-scale fraud attacks in the recent past.
“By implementing machine learning technology, we can help banks and credit card providers outsmart the criminals and build safer banking infrastructure.”
According to the Anti-Money Laundering and Countering the Financing of Terrorism Industry Partnership, lenders are looking at using data analytics to detect suspicious transactions because current systems mistakenly identify fraud, resulting in declined transactions.
-- BERNAMA
Toshiba supplies microcontroller for Thundersoft´s MCU boards
KUALA LUMPUR, Feb 21 (Bernama) -- Toshiba Electronic Devices & Storage Corporation (Toshiba) has begun supplying ‘TMPM3HQFDFG’ microcontroller for use in general-purpose MCU boards manufactured by Chinese platform technology provider, Thundersoft.
The microcontroller is Arm® Cortex®-M core-based in the TXZ™ family’s ‘M3H group’ developed for consumer and industrial equipment, according to a statement.
Thundersoft’s general-purpose MCU board integrating TXZ™ family microcontrollers are compatible with the Arm Mbed™ OS. It will be available on the China Taobao website and Thundersoft’s corporate website in other regions, starting this month.
Customers can start development immediately after the introduction of the MCU board, using an online compiler and other development environments provided free of charge by Arm.
The board is also equipped with Arduino compatible connectors and SeeedGrove connectors, both of which are widely used in the industry, and allows rapid system development with numerous commercially available shields and sensors.
Toshiba supports a wide range of customers in speeding up time to market for products and expand its semiconductor business by reflecting the needs of customers to its product development.
-- BERNAMA
Internet fraud buster Jumio among World´s Most Innovative Companies
KUALA LUMPUR, Feb 21 (Bernama) -- Jumio, the leading AI-powered trusted identity as service provider and protector of online ecosystem against fraud and bad actors, has been named in Fast Company’s annual list of the World’s Most Innovative Companies for 2019.
According to a statement, Jumio is honoured as the 29th-ranked company globally and is second in the Security category.
Fast Company’s Most Innovative Companies list honours businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world.
Jumio’s innovations, driven by Jumio Authentication, augmented intelligence, machine learning, 3D liveness detection and a seamless user experience, enables the company to become the leader in online identity proofing and ongoing authentication.
These innovations have led Jumio to become the most accurate solution in the market and one of the key leaders in both deterring and detecting online fraud as it has verified more than 160 million identities to date, issued by over 200 countries and territories.
Jumio supports large organisations across an array of sectors and continues to grow as more companies select the Internet fraud buster to protect their online businesses.
The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and road map for the future of innovation across the most dynamic sectors of the economy.
The Most Innovative Companies list issue (March-April 2019) is now available online at https://www.fastcompany.com/MIC.
For more information, contact https://www.jumio.com.
-- BERNAMA
Jumio supports large organisations across an array of sectors and continues to grow as more companies select the Internet fraud buster to protect their online businesses.
The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and road map for the future of innovation across the most dynamic sectors of the economy.
The Most Innovative Companies list issue (March-April 2019) is now available online at https://www.fastcompany.com/MIC.
For more information, contact https://www.jumio.com.
-- BERNAMA
Delhi High Court issues injunction against Sinopharm Weiqida Pharmaceuticals
KUALA LUMPUR, Feb 20 (Bernama) -- Centrient Pharmaceuticals (Centrient) today announced the Delhi High Court in India granted an injunction against Sinopharm Weiqida Pharmaceuticals and Sinopharm India - blocking the export, importation and sale of their amoxicillin active ingredient into India.
Weiqida was also found in contempt of the Delhi High Court’s original preliminary injunction order granted in April 2017, through its continued importation and sale of its amoxicillin trihydrate active pharmaceutical ingredient (API) in India.
Centrient will seek monetary compensation for the damage sustained by the illegal shipments, in violation of the preliminary injunction since April 2017.
It wishes to put all buyers of Weiqida’s amoxicillin trihydrate API in India on notice (even if such API transits through India under advanced licence) to be aware of the above orders of the Delhi High Court.
Centrient shall ensure full compliance of the orders of the court and will notify the Indian Customs Authority and other authorities to seize all future Weiqida amoxicillin shipments at the relevant customs facilities.
Centrient Chief Executive Officer, Karl Rotthier said Centrient held world-class intellectual property portfolio relating to its innovative, sustainable and environmentally-friendly amoxicillin technology.
“We will continue to rigorously defend our Intellectual Property assets worldwide as we continue to invest in our innovative R&D programmes directed to enzymatically produce, sustainable antimicrobials and statins,” he said.
Centrient, the leading manufacturer of beta-lactam antibiotics and provider of next generation statins and anti-fungals, is headquartered in Rotterdam, the Netherlands. More details at www.centrient.com
-- BERNAMA
Subscribe to:
Posts (Atom)